Dr. Jayson Rieger
Board Member
Verrica Pharmaceuticals Inc. (VRCA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Jayson Rieger
Dr. Jayson Rieger is recorded as CEO and Board Member at Verrica Pharmaceuticals Inc. (VRCA). Verrica Pharmaceuticals Inc. reported in an 8-K filed November 4, 2024 that Dr. Jayson Rieger was appointed member of the Board, effective November 5, 2024. Verrica Pharmaceuticals Inc. reported in an 8-K filed November 4, 2024 that Dr. Jayson Rieger was appointed President, Chief Executive Officer, and as member of the Board, effective November 5, 2024.
“On November 1, 2024, the Board appointed Dr. Jayson Rieger as the Company's President, Chief Executive Officer, and as member of the Board and designated him as the Company's principal executive officer, each effective as of the Effective Date.”
“On November 1, 2024, the Board appointed Dr. Jayson Rieger as the Company's President, Chief Executive Officer, and as member of the Board and designated him as the Company's principal executive officer, each effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-11-05–present
-
Current
2024-11-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Verrica Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Jayson Rieger CEO, Board Member
- John J. Kirby CFO
- John Kirby CFO
- Terry Kohler CFO, Chief Accounting Officer
- David Zawitz COO
- Charles Frantzreb Board Member
- Diem Nguyen Board Member
- Gavin Corcoran Board Member
- Lawrence Eichenfield Board Member
- Paul B. Manning Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.